Story perspectives

Synchron Secures $200M to Launch Groundbreaking Brain-Computer Interface

11/8/2025

45 9

Summary

Story summary

Synchron raised $200 million in a Series D to advance the Stentrode brain-computer interface for paralysis.
Double Point Ventures led the round, with other investors contributing, lifting total funding to $345 million.
The Stentrode is implanted via a minimally invasive catheter and enables control of digital devices by thought.
Synchron will expand engineering and cognitive artificial intelligence divisions, support pivotal trials, and prepare for commercial launch, said Tom Oxley, CEO.

1 of 1

Story summary

Synchron raised $200 million in a Series D to advance the Stentrode brain-computer interface for paralysis.
Double Point Ventures led the round, with other investors contributing, lifting total funding to $345 million.
The Stentrode is implanted via a minimally invasive catheter and enables control of digital devices by thought.
Synchron will expand engineering and cognitive artificial intelligence divisions, support pivotal trials, and prepare for commercial launch, said Tom Oxley, CEO.